AI assistant
Croda International PLC — Director's Dealing 2019
May 1, 2019
4641_dirs_2019-05-01_3da97230-8c99-44c1-97ad-256c0ef0c03f.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 8026X
Croda International PLC
01 May 2019
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
1) Thomas Michael Brophy
2) Sarah Elizabeth Brophy
2
Reason for the notification
a)
Position/status
1) Company Secretary (PDMR)
2) PCA of PDMR
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Croda International Plc
b)
LEI
2138004WCNBFJEEOXV26
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 10.609756p each
ISIN: GB00BJFFLV09
b)
Nature of the transaction
1)
Sale as detailed in c) below.
2)
Sale as detailed in c) below.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 1) 5151p | 823 |
| 2) 5142.5790p | 2,000 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregated volume | Aggregated Price |
| 1) 823 | £42,392.73 |
| 2) 2,000 | £102,851.58 |
e)
Date of the transaction
1) and 2) 2019-04-30
f)
Place of the transaction
XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHEFLFBKEFXBBB